Skip to content

Use of Bhibitak [Terminalia Belerica] In Management Of Purishaja Krimi(intestinal worms)

A Randomized Controlled Clinical Trial To Study The Effect Of Bhibitak [Terminalia Belerica] In Management Of Purishaja Krimi In School Aged Children. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088165
Enrollment
64
Registered
2025-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B814- Mixed intestinal helminthiases

Interventions

None listed

Sponsors

Self Pratik Maruti Kadu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient Will Be Selected Irrespective Of Sex, Religion, Socio-Economic Status, And Food Habit. 2.Patients Having Classical Signs And Symptoms Of Pureeshaja Krimi. 3.Presence Of Ova/Cyst/Worm In Stool (R/M) Examination

Exclusion criteria

Exclusion criteria: 1.Patient Bellow Age Group Of 6 Years And Above Age Group Of 12 Years. 2.Patients Who Need Surgical Procedures, Or Having Complications Like Intestinal Obstruction, Perforation. 3.Patients Who Are Already Dewormed In last 6 Months.

Design outcomes

Primary

MeasureTime frame
To decrease sign and symptomps of purishaja krimi after giving Bhibitak churna.Timepoint: 7day and 14day

Secondary

MeasureTime frame
to compare between trial & control drugTimepoint: 7 day 14 day

Countries

India

Contacts

Public ContactDr Sachin Prakash Gwalani

SMBT Ayurved College and Hospital

sachin.gwalani@gmail.com919834570287

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026